Cannapharmarx, Inc. (CPMD) Stock Price & Analysis
Cannapharmarx, Inc. (CPMD) fell 1.96% to USD 0 as of June 10, 2026 at 07:17 UTC, according to Nexqual real-time market data.
CPMD last closed at USD 0; the session ranged USD 0–0 on volume of 380 shares. Market capitalization is $1.70M, with a 52-week range of USD 0–0.01 (PNK). Source: Nexqual, June 10, 2026 at 07:17 UTC.
Key Statistics (as of June 10, 2026 at 07:17 UTC)
| Price | USD 0 |
|---|---|
| Change | ▼ 1.96% (down) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 380 shares |
| Market Cap | $1.70M |
| Exchange | PNK |
Technical Analysis (CPMD)
Nexqual's technical model rates CPMD "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 07:17 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 36.29 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Analyst Ratings (CPMD)
Wall Street analysts rate CPMD "None", per Nexqual as of June 10, 2026 at 07:17 UTC.
| Consensus Rating | None |
|---|
Earnings (CPMD)
Source: Nexqual, June 10, 2026 at 07:17 UTC.
Financials & Fundamentals (CPMD)
| Total Revenue | $1.65M |
|---|---|
| Revenue Growth (YoY) | +87.10% |
| Gross Margin | -146.68% |
| Operating Margin | -108.75% |
| Profit Margin | +0.00% |
| Current Ratio | 0.03 |
| Total Cash | $633 |
| Total Debt | $25.45M |
| Free Cash Flow | $-7.01M |
Source: Nexqual, June 10, 2026 at 07:17 UTC.
Financial Health Score (CPMD)
Nexqual rates Cannapharmarx, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:17 UTC.
| Growth | Strong — Revenue +87% YoY (latest Q) |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $633 cash vs $25M debt |
| Cash Flow | Weak — Operating cash flow -$431K |
| Efficiency | Mixed — No data |
Ownership (CPMD)
| Insider Ownership | +6.76% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 678.50M |
| Float | 623.90M |
Source: Nexqual, June 10, 2026 at 07:17 UTC.
Leadership (CPMD)
Cannapharmarx, Inc. is led by Constantine Nkafu (age 49), CEO & Director, per Nexqual as of June 10, 2026 at 07:17 UTC.
| CEO & Director | Constantine Nkafu (age 49) |
|---|---|
| Chief Financial Officer | Oliver W. Foeste C.A. (age 48) |
From Cannapharmarx, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GREH | Green Rain Energy Holdings Inc. | USD 0.01 | ▼ 4.03% |
| ADTI | Adapti, Inc. | USD 3 | ▲ 26.37% |
| CANL | CANNLABS INC | USD 0 | ▲ 0% |
| SPONF | SPONSORSONE INC | USD 0 | ▲ 0% |
| RSSFF | Affinor Growers, Inc. | USD 0.03 | ▲ 1.54% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:17 UTC. This page is informational and not investment advice.